01 6Nexgard
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 958
2019 Revenue in Millions : 881
Growth (%) : 9
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 1,009
2020 Revenue in Millions : 958
Growth (%) : 14
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 1,153
2021 Revenue in Millions : 1,009
Growth (%) : 14
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 1,282
2022 Revenue in Millions : 1,153
Growth (%) : 13
Main Therapeutic Indication : Parasitic Infections
Currency : USD
2018 Revenue in Millions : 689
2017 Revenue in Millions : 617
Growth (%) : 12%
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 807
2018 Revenue in Millions : 665
Growth (%) : 21
LOOKING FOR A SUPPLIER?
